Strategic Wealth Partners, Ltd. Abbott Laboratories Transaction History

Strategic Wealth Partners, Ltd.

$947 Million
Q3 2024

A detailed history of Strategic Wealth Partners, Ltd. transactions in Abbott Laboratories stock. As of the latest transaction made, Strategic Wealth Partners, Ltd. holds 7,211 shares of ABT stock, worth $835,754. This represents 0.09% of its overall portfolio holdings.

Number of Shares

7,211

Previous 7,476 3.54%

Holding current value

$835,754

Previous $776,000 5.93%

% of portfolio

0.09%

Previous 0.08%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	SELL	$100.07 - $118.13 $26,518 - $31,304	-265 Reduced 3.54%	7,211 $822,000
Q2 2024 Oct 08, 2024	SELL	$100.73 - $112.44 $22,764 - $25,411	-226 Reduced 2.93%	7,476 $776,000
Q1 2024 May 20, 2024	BUY	$109.52 - $120.96 $125,400 - $138,499	1,145 Added 17.46%	7,702 $875,000
Q4 2023 May 20, 2024	SELL	$90.19 - $110.4 $94,428 - $115,588	-1,047 Reduced 13.77%	6,557 $721,000
Q3 2023 May 20, 2024	SELL	$95.53 - $114.62 $93,905 - $112,671	-983 Reduced 11.45%	7,604 $736,000
Q2 2023 May 20, 2024	BUY	$100.78 - $112.29 $23,683 - $26,388	235 Added 2.81%	8,587 $936,000
Q1 2023 Apr 24, 2023	SELL	$96.86 - $114.01 $25,183 - $29,642	-260 Reduced 3.02%	8,352 $845,000
Q4 2022 Apr 24, 2023	BUY	$95.06 - $111.52 $57,226 - $67,135	602 Added 7.52%	8,612 $945,000
Q3 2022 Apr 24, 2023	BUY	$96.76 - $112.03 $21,867 - $25,318	226 Added 2.9%	8,010 $775,000
Q2 2022 Aug 22, 2022	SELL	$102.07 - $123.37 $100,028 - $120,902	-980 Reduced 11.18%	7,784 $846,000
Q1 2022 May 19, 2022	SELL	$114.02 - $139.04 $157,803 - $192,431	-1,384 Reduced 13.64%	8,764 $1.04 Million
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $5,892 - $7,214	-51 Reduced 0.5%	10,148 $1.43 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $46,664 - $51,624	400 Added 4.08%	10,199 $1.21 Million
Q2 2021 Aug 25, 2021	BUY	$105.79 - $124.53 $741,270 - $872,581	7,007 Added 250.97%	9,799 $1.14 Million
Q1 2021 May 24, 2021	SELL	$108.84 - $128.23 $861,250 - $1.01 Million	-7,913 Reduced 73.92%	2,792 $335,000
Q4 2020 Feb 18, 2021	SELL	$105.0 - $114.42 $43,050 - $46,912	-410 Reduced 3.69%	10,705 $1.17 Million
Q3 2020 Nov 10, 2020	SELL	$91.64 - $111.29 $321,564 - $390,516	-3,509 Reduced 23.99%	11,115 $1.21 Million
Q2 2020 Aug 11, 2020	SELL	$76.57 - $98.0 $306,509 - $392,294	-4,003 Reduced 21.49%	14,624 $1.34 Million
Q1 2020 May 07, 2020	BUY	$62.82 - $91.86 $1.17 Million - $1.71 Million	18,627 New	18,627 $1.62 Million
Q4 2019 Jan 30, 2020	SELL	$78.51 - $87.4 $1.37 Million - $1.53 Million	-17,466 Closed	0 $0
Q3 2019 Oct 28, 2019	BUY	$81.84 - $88.74 $1.4 Million - $1.52 Million	17,075 Added 4367.01%	17,466 $20.4 Million
Q2 2019 Aug 06, 2019	BUY	$72.88 - $85.0 $16,033 - $18,700	220 Added 128.65%	391 $32,000
Q1 2019 May 14, 2019	BUY	$66.22 - $80.06 $4,701 - $5,684	71 Added 71.0%	171 $14,000
Q4 2018 Jan 24, 2019	SELL	$65.56 - $74.27 $26,224 - $29,708	-400 Reduced 80.0%	100 $7,000
Q3 2018 Dec 06, 2018	SELL	$60.81 - $73.36 $2,189 - $2,640	-36 Reduced 6.72%	500 $37,000
Q1 2018 Jul 13, 2018	BUY	$56.27 - $63.62 $30,160 - $34,100	536 New	536 $32,000

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Strategic Wealth Partners, Ltd. with notifications on news.

Account

Strategic Wealth Partners, Ltd. Abbott Laboratories Transaction History